MedTrace Logo

Fetuin A as a Predictor of Deterioration of Renal Function in Hypertonic Patients

NCT05963126 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-07-27

No results posted yet for this study

Summary

Commonly used parameters (creatinine, estimated glomerular filtration rate, and urine albumin/creatinine ratio) for prediction of decline of renal function are sensitive for advanced kidney impairment. Modified human urine Fetuin A (urine Fetuin A) with specific modification in urine (Fetuin A) can earlier predict the progression of kidney disease in patients with diabetes. Studies evaluating urine Fetuin A in hypertonic patients are still lacking.

Conditions

  • Arterial Hypertension

Interventions

OTHER

No intervention.

No intervention.

Sponsors & Collaborators

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Zdeněk Ramík, MD · University Hospital Ostrava

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05963126 on ClinicalTrials.gov